3 Growth Stocks Trading Near Their 52-Week Lows to Buy Right Now
There are plenty of growth stocks trading at obscenely high valuations right now. Part of the reason for that is…
1.468,60SEK
3,91%
Echtzeit-Aktienkurs AstraZeneca PLC
Bid:
Ask:
Nachrichten zur AstraZeneca PLC Aktie
AstraZeneca Is No Longer a Sell for Any Analyst as UBS Upgrades
AstraZeneca Plc’s recent share-price rout has gone so far that the pharma stock has shaken off the last of its…
NATIONAL UNIVERSITY HEALTH SYSTEM, SAHLGRENSKA UNIVERSITY HOSPITAL AND INDUSTRY PARTNERS, ASTRAZENECA AND ERICSSON ESTABLISH GLOBAL HEALTH INNOVATION NETWORK
20 November 2024
SINGAPORE — The National University Health System (NUHS) and Sahlgrenska University Hospital have formed a strategic partnership with…
ANALYSE-FLASH: UBS hebt Astrazeneca auf 'Neutral' - Ziel 11300 Pence
ZÜRICH (dpa-AFX Broker) - Die Schweizer Großbank UBS hat die Aktien von Astrazeneca nach ihrem…
ANALYSE-FLASH: UBS hebt Astrazeneca auf Neutral - Ziel 11300 Pence
ZÜRICH (dpa-AFX Broker) - Die Schweizer Großbank UBS hat die Aktien von Astrazeneca nach ihrem Kursrutsch bei unverändertem Kursziel…
UBS hebt Astrazeneca auf Neutral - Ziel 11300 Pence
ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Aktien von Astrazeneca nach ihrem Kursrutsch bei unverändertem Kursziel von…
International business development expert joins Dicot Pharma
Uppsala, Sweden, November 19, 2024. The potency drug developer Dicot Pharma, which recently initiated a phase 2a clinical trial and…
Tagrisso recommended for EU approval - LAURA
18 November 2024
Tagrisso recommended for approval in the EU by CHMP
for patients with unresectable EGFR-mutated lung cancer
Recommendation based on LAURA Phase III…
FIVE at FIVE: GSK, AstraZeneca plummet; LandSec profits; Economy stalls; FTSE 100 meanders; TT snubs Volex
1. Trump anti-vax health appointment wipes £7bn from AstraZeneca and GSK President-elect Donald Trump announced the controversial appointment of Robert…
Trump anti-vax health appointment wipes £7bn from AstraZeneca and GSK
Almost £7 billion was wiped from the combined market values of GSK PLC and AstraZeneca PLC on Friday after Donald Trump unveiled his…
Is AstraZeneca a Buy as It Eyes the Weight Loss Market?
AstraZeneca just released some encouraging data about its weight loss drug candidates.…
AstraZeneca: Strong Growth Potential And Market Volatility Offer Opportunity
…
AstraZeneca Aktie: Sorgen um möglichen Skandal in China
Kulmbach (www.aktiencheck.de) - AstraZeneca-Aktienanalyse von "Der Aktionär":
Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…
Healthy Returns: AstraZeneca expands U.S. investment plan on confidence in economy
AstraZeneca said it is doubling down on its investment in its U.S. business. Meanwhile, General Catalyst has agreed to purchase…
Deutsche Bank belässt Astrazeneca auf Hold - Ziel 10500 Pence
FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat Astrazeneca auf "Hold" mit einem Kursziel von 10500 Pence belassen. Er habe…
AstraZeneca investiert $3,5 Milliarden in R&D und Produktion in den Vereinigten Staaten
CAMBRIDGE, England--(BUSINESS WIRE)--AstraZeneca hat heute Investitionen von $3,5 Milliarden in den Vereinigten Staaten angekündigt. Bis Ende 2026 sollen dort Forschung…
AstraZeneca Plc (AZN) Q3 2024 Earnings Call Transcript
AZN earnings call for the period ending September 30, 2024.…
AstraZeneca PLC 2024 Q3 - Results - Earnings Call Presentation
…
AstraZeneca PLC (AZN) Q3 2024 Earnings Call Transcript
…
AstraZeneca Talks Up US Growth as China Problems Fester
AstraZeneca Plc is increasingly looking to the US for growth as its once fast-expanding China business slows amid a probe…
AstraZeneca Lifts Outlook, Plans $3.5B US Investment
British drugmaker AstraZeneca increased its full-year sales outlook on booming demand for its cancer and rare-disease drugs, and said it…
Trending tickers: The latest investor updates on Coinbase, Tesla, AstraZeneca, Metro Bank and SoftBank
The latest investor updates on stocks that are trending on Tuesday.…
ROUNDUP: Astrazeneca hebt Jahresziele erneut - Milliardeninvestition in den USA
CAMBRIDGE (dpa-AFX) - Eine hohe Nachfrage vor allem nach seinen Medikamenten gegen Krebs und seltene Krankheiten sorgt beim Pharmakonzern Astrazeneca…
ROUNDUP: Astrazeneca hebt Jahresziele erneut - Milliardeninvestition in den USA
CAMBRIDGE (dpa-AFX) - Eine hohe Nachfrage vor allem nach seinen Medikamenten gegen Krebs und seltene Krankheiten…
AstraZeneca raises 2024 outlook on strong Q3 By Investing.com
AstraZeneca raises 2024 outlook on strong Q3…
AstraZeneca shares present an opportunity after strong Q3 results
The UK’s second-largest listed company by market cap (at the time of writing) presents an opportunity for investors after releasing…
Astrazeneca plant Milliardeninvestionen in USA - 'Attraktives Geschäftsumfeld'
CAMBRIDGE (dpa-AFX) - Nur wenige Tage nach den richtungsweisenden US-Präsidentschaftswahlen hat der britisch-schwedische Pharmakonzern Astrazeneca …
Astrazeneca plant Milliardeninvestionen in USA - Attraktives Geschäftsumfeld
CAMBRIDGE (dpa-AFX) - Nur wenige Tage nach den richtungsweisenden US-Präsidentschaftswahlen hat der britisch-schwedische Pharmakonzern Astrazeneca dort milliardenschwere Investitionen angekündigt.…
AstraZeneca lifts 2024 revenue and profit forecast after Q3 beat By Reuters
AstraZeneca lifts 2024 revenue and profit forecast after Q3 beat…
Geschäfte florieren: Pharmahersteller Astrazeneca hebt Jahresziele erneut an
CAMBRIDGE (dpa-AFX) - Eine hohe Nachfrage vor allem nach seinen Medikamenten gegen Krebs und seltene Krankheiten…
AstraZeneca invests $3.5 billion in US
12 November 2024
AstraZeneca invests $3.5 billion
in R&D and manufacturing in the United States
AstraZeneca today announces $3.5 billion of capital investment…
Dato-DXd new BLA submitted, NSQ BLA withdrawn
12 November 2024
Datopotamab deruxtecan new BLA submitted for accelerated approval in the US for patients with previously treated advanced EGFR-mutated non-small…
9M and Q3 2024 Results
AstraZeneca
12 November 2024
9M and Q3 2024 results
Upgrade to full year 2024 guidance underpinned by strong underlying growth momentum
Revenue and EPS…
AstraZeneca Beats on Q3 Earnings, Ups 2024 View, to Invest $3.5B in US
AZN beats third-quarter estimates for earnings and sales. It raises its sales and profit outlook for 2024 for the second…
AstraZeneca’s China-Fueled Plunge May Be Difficult to Shake Off
AstraZeneca Plc started the week with a market valuation of about £171 billion ($222 billion). By the close on Thursday…
AstraZeneca: Contrarian Buy After The China Challenge (Rating Upgrade)
…
AstraZeneca Says Current, Former Executives Involved in China Probe
Two current and two former senior AstraZeneca Plc executives in the group’s China unit are under investigation in a probe…
AstraZeneca Aktie: Kursrückgang übertrieben
Toronto (www.aktiencheck.de) - AstraZeneca-Aktienanalyse von BMO Capital Markets:
1. Überblick über die Situation
AstraZeneca plc (ISIN: GB0009895292, WKN: 886455, Ticker-Symbol: ZEG, London…
ANALYSE-FLASH: Deutsche Bank Research hebt Astrazeneca auf 'Hold'
FRANKFURT (dpa-AFX) - Deutsche Bank Research hat Astrazeneca bei einem unveränderten Kursziel von 10500 Pence…
ANALYSE-FLASH: Deutsche Bank Research hebt Astrazeneca auf Hold
FRANKFURT (dpa-AFX) - Deutsche Bank Research hat Astrazeneca bei einem unveränderten Kursziel von 10500 Pence von "Sell" auf "Hold"…
AstraZeneca Aktie: China-Bedenken übertrieben - Kursrückgang als Kaufchance!
Charlotte (www.aktiencheck.de) - AstraZeneca-Aktienanalyse von BofA Securities:
Aktuelle Bewertung
Die Analysten von BofA Securities stufen die Aktie von AstraZeneca plc (ISIN: GB0009895292,…
Buy, Sell, or Hold AstraZeneca Stock? Key Tips Ahead of Q3 Earnings
AstraZenecas key medicines, mainly cancer drugs, Lynparza, Tagrisso and Imfinzi, and diabetes medicine Farxiga are expected to have driven the…
AstraZeneca shares fall on report of potential China probe fallout
AstraZeneca shares recorded their worst day since March 2020.…
FIVE at FIVE: Primark profits up; AstraZeneca, FTSE 100 slip; Trump trades higher; ASOS losses escalate
1. Primark owner ABF hikes dividend, buyback as profit jumps “We delivered a substantial improvement in profitability, excellent cash generation…
AstraZeneca sheds £15bn in value on weight loss drug data, China fraud report
AstraZeneca PLC (LSE:AZN) shed £15 billion in value on Tuesday following early data on its weight loss drugs and reports dozens…
GOLDMAN SACHS stuft ASTRAZENECA auf Buy
NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat die Einstufung für Astrazeneca mit einem Kursziel von 16046 Pence…
UBS stuft ASTRAZENECA auf Sell
ZÜRICH (dpa-AFX Analyser) - Die schweizerische Großbank UBS hat die Einstufung für Astrazeneca auf "Sell" mit einem Kursziel von 11.300…
Total Voting Rights
1 November 2024 15:00 GMT
Transparency Directive
Voting rights and capital
The following notification is made in accordance with the UK Financial Conduct…
AstraZeneca says its China operations president under investigation
AstraZenecas China president is under investigation and is cooperating with Chinese authorities, the company said on Wednesday, sending shares down…
AZN China President under investigation
This announcement contains inside information
30 October 2024
AstraZeneca China President currently under investigation
Leon Wang, Executive Vice President International and AstraZeneca China…